“…Structures provide the means to see where inhibitors are binding and what they may do to the target protein structure. Combined computational and experimental X-ray crystallographic structures can efficiently and accurately identify small molecule-binding fragments important for inhibition and inform the design of new inhibitors based upon the observed ligand-bound structure (Blundell et al, 2006; Erlanson, Fesik, Hubbard, Jahnke, & Jhoti, 2016; Moiani et al, 2009; Murray & Blundell, 2010; Perry, Harris, Moiani, Olson, & Tainer, 2009; Thomas et al, 2017; Winter et al, 2012). Starting from small fragments bound to a protein, further optimization including merging adjacent fragments with a linker can lead to the generation of better inhibitors.…”